Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12ala polymorphism in the pparγ gene

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 772-775

  Hara, Manami ^a   Alcoser, Sergio Y ^a   Qaadir, Arshia ^a   Beiswenger, Kristina K ^a   Cox, Nancy J ^a   Ehrmann, David A ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANDROGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; THIAZOLIDINE DERIVATIVE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CAUCASIAN; CLINICAL FEATURE; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GLUCOSE INTOLERANCE; HETEROZYGOTE; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HUMANS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

FALLOPIA;

EID: 0036170755     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.2.772     Document Type: Article

References (25)

1. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study
2. Detection of functional ovarian hyperandrogenism in women with androgen excess
3. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
4. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
5. Prevalence and predictors of risk for type 2 diabetes melbtus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
6. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
7. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
8. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
9. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary, syndrome
10. PPAR-γ: Adipogenic regulator and thiazolidinedione receptor
11. 12Ala subsitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
12. 12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients
13. 12Ala polymorphism is associated with decreased risk of type 2 diabetes
14. 12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes
15. 12Ala gene variant is strongly associated with larger body mass in the Taiwanese
16. 12Ala variant of peroxisome proliferator-activated receptor-12 (PPAR-γ2) is associated with measures of obesity in Mexican Americans
17. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women
18. 12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
19. 12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
20. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach
21. Report of the expert committee on the diagnosis and classification of diabetes mellitus
22. Immunoassay of insulin: Two antibody systems: Plasma insulin levels of normal, subdiabetic and diabetic rats
23. Plasma testosterone binding globulin and indexes of the concentration of unbound androgens in normal and hirsute subjects
24. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus
25. 1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome